4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001193125-26-208632
EVP and Chief Medical Officer sold 344 shares at $24.96 ($8,586)
From the SEC's structured data for this filing
Trades in this filing
Crombez Eric · EVP and Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-05 | Sale : show line 1 in the form | −344 | $24.96 | $8,586 | 111,189 | D |
| Open-market sales · 344 sh · avg $24.96 · $8,586 | ||||||
Loading xslF345X06/ownership.xml…